Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Prey and Venom Efficacy of Male and Female Wandering Spider, Phoneutria boliviensis (Araneae: Ctenidae).

Valenzuela-Rojas JC, González-Gómez JC, van der Meijden A, Cortés JN, Guevara G, Franco LM, Pekár S, García LF.

Toxins (Basel). 2019 Oct 27;11(11). pii: E622. doi: 10.3390/toxins11110622.

2.

Evolution of aerial spider webs coincided with repeated structural optimization of silk anchorages.

Wolff JO, Paterno GB, Liprandi D, Ramírez MJ, Bosia F, van der Meijden A, Michalik P, Smith HM, Jones BR, Ravelo AM, Pugno N, Herberstein ME.

Evolution. 2019 Oct;73(10):2122-2134. doi: 10.1111/evo.13834. Epub 2019 Sep 10.

PMID:
31441504
3.

Transcriptome annotation and characterization of novel toxins in six scorpion species.

Grashof DGB, Kerkkamp HMI, Afonso S, Archer J, Harris DJ, Richardson MK, Vonk FJ, van der Meijden A.

BMC Genomics. 2019 Aug 13;20(1):645. doi: 10.1186/s12864-019-6013-6.

4.

Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles.

van der Weide H, Vermeulen-de Jongh DMC, van der Meijden A, Boers SA, Kreft D, Ten Kate MT, Falciani C, Pini A, Strandh M, Bakker-Woudenberg IAJM, Hays JP, Goessens WHF.

Int J Antimicrob Agents. 2019 Aug;54(2):159-166. doi: 10.1016/j.ijantimicag.2019.05.019. Epub 2019 Jun 5.

PMID:
31173867
5.

Assessment of the Additional Value of Verapamil to a Moxifloxacin and Linezolid Combination Regimen in a Murine Tuberculosis Model.

Pieterman ED, Te Brake LHM, de Knegt GJ, van der Meijden A, Alffenaar JC, Bax HI, Aarnoutse RE, de Steenwinkel JEM.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e01354-18. doi: 10.1128/AAC.01354-18. Print 2018 Sep.

6.

Self-righting potential and the evolution of shell shape in Galápagos tortoises.

Chiari Y, van der Meijden A, Caccone A, Claude J, Gilles B.

Sci Rep. 2017 Nov 30;7(1):15828. doi: 10.1038/s41598-017-15787-7.

7.

Target-Specificity in Scorpions; Comparing Lethality of Scorpion Venoms across Arthropods and Vertebrates.

van der Meijden A, Koch B, van der Valk T, Vargas-Muñoz LJ, Estrada-Gómez S.

Toxins (Basel). 2017 Oct 4;9(10). pii: E312. doi: 10.3390/toxins9100312.

8.

Distinct spinning patterns gain differentiated loading tolerance of silk thread anchorages in spiders with different ecology.

Wolff JO, van der Meijden A, Herberstein ME.

Proc Biol Sci. 2017 Jul 26;284(1859). pii: 20171124. doi: 10.1098/rspb.2017.1124.

9.

The role of the time-kill kinetics assay as part of a preclinical modeling framework for assessing the activity of anti-tuberculosis drugs.

Bax HI, Bakker-Woudenberg IAJM, de Vogel CP, van der Meijden A, Verbon A, de Steenwinkel JEM.

Tuberculosis (Edinb). 2017 Jul;105:80-85. doi: 10.1016/j.tube.2017.04.010. Epub 2017 Apr 27.

PMID:
28610791
10.

Characterizing the biological and biochemical profile of six different scorpion venoms from the Buthidae and Scorpionidae family.

Estrada-Gómez S, Gomez-Rave L, Vargas-Muñoz LJ, van der Meijden A.

Toxicon. 2017 May;130:104-115. doi: 10.1016/j.toxicon.2017.02.007. Epub 2017 Feb 13.

PMID:
28209477
11.

Activity of moxifloxacin and linezolid against Mycobacterium tuberculosis in combination with potentiator drugs verapamil, timcodar, colistin and SQ109.

de Knegt GJ, van der Meijden A, de Vogel CP, Aarnoutse RE, de Steenwinkel JE.

Int J Antimicrob Agents. 2017 Mar;49(3):302-307. doi: 10.1016/j.ijantimicag.2016.11.027. Epub 2017 Feb 2.

PMID:
28162983
12.

A biomechanical view on stinger diversity in scorpions.

van der Meijden A, Kleinteich T.

J Anat. 2017 Apr;230(4):497-509. doi: 10.1111/joa.12582. Epub 2016 Dec 28.

13.

Colistin as a potentiator of anti-TB drug activity against Mycobacterium tuberculosis.

Bax HI, de Steenwinkel JE, Ten Kate MT, van der Meijden A, Verbon A, Bakker-Woudenberg IA.

J Antimicrob Chemother. 2015 Oct;70(10):2828-37. doi: 10.1093/jac/dkv194. Epub 2015 Jul 16.

PMID:
26183185
14.

Variability in venom volume, flow rate and duration in defensive stings of five scorpion species.

van der Meijden A, Coelho P, Rasko M.

Toxicon. 2015 Jun 15;100:60-6. doi: 10.1016/j.toxicon.2015.04.011. Epub 2015 Apr 24.

PMID:
25911958
15.

Toxicity of scorpion venom in chick embryo and mealworm assay depending on the use of the soluble fraction versus the whole venom.

van der Valk T, van der Meijden A.

Toxicon. 2014 Sep;88:38-43. doi: 10.1016/j.toxicon.2014.06.007. Epub 2014 Jun 19.

PMID:
24951875
16.

Deep intraspecific divergences in the medically relevant fat-tailed scorpions (Androctonus, Scorpiones).

Coelho P, Sousa P, Harris DJ, van der Meijden A.

Acta Trop. 2014 Jun;134:43-51. doi: 10.1016/j.actatropica.2014.02.002. Epub 2014 Feb 11.

PMID:
24524948
17.

Choose your weapon: defensive behavior is associated with morphology and performance in scorpions.

van der Meijden A, Lobo Coelho P, Sousa P, Herrel A.

PLoS One. 2013 Nov 13;8(11):e78955. doi: 10.1371/journal.pone.0078955. eCollection 2013.

18.

Functional morphology and bite performance of raptorial chelicerae of camel spiders (Solifugae).

van der Meijden A, Langer F, Boistel R, Vagovic P, Heethoff M.

J Exp Biol. 2012 Oct 1;215(Pt 19):3411-8. doi: 10.1242/jeb.072926. Epub 2012 Jul 5.

19.

Phylogeography of Sardinian cave salamanders (genus Hydromantes) is mainly determined by geomorphology.

Chiari Y, van der Meijden A, Mucedda M, Lourenço JM, Hochkirch A, Veith M.

PLoS One. 2012;7(3):e32332. doi: 10.1371/journal.pone.0032332. Epub 2012 Mar 12.

20.

Packing a pinch: functional implications of chela shapes in scorpions using finite element analysis.

van der Meijden A, Kleinteich T, Coelho P.

J Anat. 2012 May;220(5):423-34. doi: 10.1111/j.1469-7580.2012.01485.x. Epub 2012 Feb 23.

21.

Base composition, selection, and phylogenetic significance of indels in the recombination activating gene-1 in vertebrates.

Chiari Y, van der Meijden A, Madsen O, Vences M, Meyer A.

Front Zool. 2009 Dec 16;6:32. doi: 10.1186/1742-9994-6-32.

22.

History and structure of the closed pedigreed population of Icelandic Sheepdogs.

Oliehoek PA, Bijma P, van der Meijden A.

Genet Sel Evol. 2009 Aug 6;41:39. doi: 10.1186/1297-9686-41-39.

23.

Phylogenetic relationships of Sardinian cave salamanders, genus Hydromantes, based on mitochondrial and nuclear DNA sequence data.

van der Meijden A, Chiari Y, Mucedda M, Carranza S, Corti C, Veith M.

Mol Phylogenet Evol. 2009 May;51(2):399-404. doi: 10.1016/j.ympev.2008.12.011. Epub 2008 Dec 24. No abstract available.

PMID:
19136065
24.

Patterns of endemism and species richness in Malagasy cophyline frogs support a key role of mountainous areas for speciation.

Wollenberg KC, Vieites DR, van der Meijden A, Glaw F, Cannatella DC, Vences M.

Evolution. 2008 Aug;62(8):1890-907. doi: 10.1111/j.1558-5646.2008.00420.x. Epub 2008 May 13.

PMID:
18485110
25.

Optimal treatment for intermediate- and high-risk, nonmuscle-invasive bladder cancer.

van der Meijden AP.

ScientificWorldJournal. 2006 Mar 9;6:2611-6. Review.

26.

Nuclear gene phylogeny of narrow-mouthed toads (Family: Microhylidae) and a discussion of competing hypotheses concerning their biogeographical origins.

van der Meijden A, Vences M, Hoegg S, Boistel R, Channing A, Meyer A.

Mol Phylogenet Evol. 2007 Sep;44(3):1017-30. Epub 2007 Feb 16.

PMID:
17369057
27.

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DW, Kurth K.

Eur Urol. 2006 Mar;49(3):466-5; discussion 475-7. Epub 2006 Jan 17.

PMID:
16442208
28.

High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder.

Sylvester RJ, van der Meijden A, Witjes JA, Jakse G, Nonomura N, Cheng C, Torres A, Watson R, Kurth KH.

Urology. 2005 Dec;66(6 Suppl 1):90-107. Review.

PMID:
16399418
29.

EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situ.

van der Meijden AP, Sylvester R, Oosterlinck W, Solsona E, Boehle A, Lobel B, Rintala E; EAU Working Party on Non Muscle Invasive Bladder Cancer.

Eur Urol. 2005 Sep;48(3):363-71.

PMID:
15994003
30.

A previously unrecognized radiation of ranid frogs in Southern Africa revealed by nuclear and mitochondrial DNA sequences.

van der Meijden A, Vences M, Hoegg S, Meyer A.

Mol Phylogenet Evol. 2005 Dec;37(3):674-85. Epub 2005 Jun 21.

PMID:
15975829
32.

Comparative performance of the 16S rRNA gene in DNA barcoding of amphibians.

Vences M, Thomas M, van der Meijden A, Chiari Y, Vieites DR.

Front Zool. 2005 Mar 16;2(1):5.

33.
34.

One immediate postoperative instillation of chemotherapy in low risk Ta, T1 bladder cancer patients. Is it always safe?

Oddens JR, van der Meijden AP, Sylvester R.

Eur Urol. 2004 Sep;46(3):336-8.

PMID:
15306104
35.

EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma.

Oosterlinck W, Solsona E, van der Meijden AP, Sylvester R, Böhle A, Rintala E, Lobel B; European Association of Urology.

Eur Urol. 2004 Aug;46(2):147-54.

PMID:
15245806
37.

Maintenance Bacillus Calmette-Guerin for Ta T1 bladder tumors is not associated with increased toxicity: results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial.

van der Meijden AP, Sylvester RJ, Oosterlinck W, Hoeltl W, Bono AV; EORTC Genito-Urinary Tract Cancer Group.

Eur Urol. 2003 Oct;44(4):429-34.

PMID:
14499676
38.
39.

The use of the marker tumor concept in Ta, T1 bladder cancer: is it justified?

van der Meijden AP.

Urol Oncol. 2002 Jan-Feb;7(1):31-3.

PMID:
12474538
41.

Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies.

Brausi M, Collette L, Kurth K, van der Meijden AP, Oosterlinck W, Witjes JA, Newling D, Bouffioux C, Sylvester RJ; EORTC Genito-Urinary Tract Cancer Collaborative Group.

Eur Urol. 2002 May;41(5):523-31.

PMID:
12074794
42.

Cytogenetic and molecular analysis of early stage renal cell carcinomas in a family with a translocation (2;3)(q35;q21).

Bodmer D, Eleveld M, Ligtenberg M, Weterman M, van der Meijden A, Koolen M, Hulsbergen-van der Kaa C, Smits A, Smeets D, Geurts van Kessel A.

Cancer Genet Cytogenet. 2002 Apr 1;134(1):6-12.

PMID:
11996788
43.

Intravesical BCG in patients with carcinoma in situ of the urinary bladder: long-term results of EORTC GU Group phase II protocol 30861.

Jakse G, Hall R, Bono A, Höltl W, Carpentier P, Spaander JP, van der Meijden AP, Sylvester R.

Eur Urol. 2001 Aug;40(2):144-50.

PMID:
11528191
45.

Non-specific immunotherapy with bacille Calmette-Guérin (BCG).

van der Meijden AP.

Clin Exp Immunol. 2001 Feb;123(2):179-80. Review. No abstract available.

47.

Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group.

Kurth KH, Bouffioux C, Sylvester R, van der Meijden AP, Oosterlinck W, Brausi M.

Eur Urol. 2000;37 Suppl 3:1-9. Review.

PMID:
10828681
48.

Significance of bladder biopsies in Ta,T1 bladder tumors: a report from the EORTC Genito-Urinary Tract Cancer Cooperative Group. EORTC-GU Group Superficial Bladder Committee.

van der Meijden A, Oosterlinck W, Brausi M, Kurth KH, Sylvester R, de Balincourt C.

Eur Urol. 1999 Apr;35(4):267-71.

PMID:
10419345
49.

Practical aspects of clinical trials on chemoprevention of prostate cancer.

van der Meijden AP.

Eur Urol. 1999;35(5-6):515-8. Review.

PMID:
10325517
50.

Bladder cancer.

van der Meijden AP.

BMJ. 1998 Nov 14;317(7169):1366-9. Review. No abstract available.

Supplemental Content

Loading ...
Support Center